Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

81.04USD
12 Feb 2016
Change (% chg)

$2.00 (+2.53%)
Prev Close
$79.04
Open
$79.54
Day's High
$81.11
Day's Low
$78.61
Volume
462,213
Avg. Vol
435,397
52-wk High
$84.84
52-wk Low
$61.40

EW.N

Chart for EW.N

About

Edwards Lifesciences Corporation is focused on technologies that treat structural heart disease and critically ill patients. The Company is engaged in the development and commercialization of heart valve therapies. It is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or... (more)

Overall

Beta: 0.60
Market Cap(Mil.): $17,481.11
Shares Outstanding(Mil.): 215.71
Dividend: --
Yield (%): --

Financials

Search Stocks

BRIEF-Edwards Lifesciences Q4 GAAP earnings per share $0.64

* Q4 Transcatheter Heart Valve therapy (THV) sales $334.3 million, up 25 percent

03 Feb 2016

Edwards Lifesciences boosts full-year profit outlook

Feb 2 Edwards Lifesciences Corp raised its full-year earnings forecast on Tuesday, anticipating stronger sales of its artificial heart valves implanted in a minimally invasive procedure that spares patients from open-chest surgery.

03 Feb 2016

UPDATE 2-Edwards Lifesciences lifts outlook on heart valve demand

Oct 26 Edwards Lifesciences Corp reported better-than-expected third-quarter earnings and raised its full-year forecast on Monday, citing strong demand for its replacement heart valves that are implanted in minimally invasive procedures.

27 Oct 2015

Edwards Lifesciences net income up on heart valve sales

Oct 26 Edwards Lifesciences Corp on Monday reported stronger-than-expected third-quarter earnings on demand for its replacement heart valves that are implanted in minimally invasive procedures.

27 Oct 2015

Earnings vs. Estimates

Search Stocks